Recent APRE Stock Price | APRE Stock Predictions | |
$5.35 | +192.90% |
$15.67 |
Recent APRE Analyst Ratings Breakdown, Making APRE Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the APRE stock predictions from the analysts covering Aprea Therapeutics Inc, we have collected all of the individual APRE stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering APRE (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since APRE stock predictions may vary widely, another useful metric to consider is the median APRE stock prediction, which represents the price at which half of the analysts
made APRE stock predictions that were higher and half made APRE stock predictions that were lower. This makes for a different take on the APRE stock predictions out there, as compared to average or mean.
And that median across all the individual APRE stock predictions was: $16.0 as of 2024-04-26.
The very highest of the APRE stock predictions for one year price target was $20.0, while the very lowest of the APRE stock predictions in the analyst group was
$11.0 (with a standard deviation of $4.509). Get the latest Zacks research report on APRE — FREE
Find out: APRE next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CLI Stock Predictions
PVBC Stock Predictions
CHUY Stock Predictions
BVH Stock Predictions
PHG Stock Predictions
DAN Stock Predictions
NEOG Stock Predictions
RFIL Stock Predictions
OPCH Stock Predictions
|
|
Strong Buy (4.00 out of 4) 99th percentile
(ranked higher than approx. 99% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |